IgG2b Isotype Control Monoklonaler Antikörper
IgG2b Isotype Control Monoklonal Antikörper für FC
Wirt / Isotyp
Maus / IgG2b, kappa
Getestete Reaktivität
n/a
Anwendung
FC
Konjugation
APC Fluorescent Dye
CloneNo.
MPC-11
Kat-Nr. : APC-65128
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in FC | humane PBMCs |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Veröffentlichte Anwendungen
| FC | See 3 publications below |
Produktinformation
APC-65128 bindet in FC IgG2b Isotype Control und zeigt Reaktivität mit n/a
| Getestete Reaktivität | n/a |
| Wirt / Isotyp | Maus / IgG2b, kappa |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | k.A. |
| Vollständiger Name | immunoglobulin heavy chain 3 (serum IgG2b) |
| Gene symbol | IgG2b Isotype Control |
| Gene ID (NCBI) | 16016 |
| Konjugation | APC Fluorescent Dye |
| Excitation/Emission maxima wavelengths | 650 nm / 660 nm |
| Form | Liquid |
| Reinigungsmethode | Affinitätsreinigung |
| Lagerungspuffer | PBS with 0.09% sodium azide and 0.5% BSA |
| Lagerungsbedingungen | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Hintergrundinformationen
The MPC-11 immunoglobulin is useful as an isotype-matched control. The MPC-11 immunoglobulin has an unknown binding specificity and is used as an isotype control for mouse IgG2b antibodies. This antibody has been quality-tested for flow cytometry as negative control.
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| FC protocol for APC IgG2b Isotype Control antibody APC-65128 | Download protocol |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
| Species | Application | Title |
|---|---|---|
MedComm (2020) CircMALAT1 promotes cancer stem-like properties and chemoresistance via regulating Musashi-2/c-Myc axis in esophageal squamous cell carcinoma | ||
Adv Mater An OMV-Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy | ||
Eur J Pharmacol PPARγ agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation | ||
Auris Nasus Larynx Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma |
